Growth Hormone Secretagogues · Research deep dive
IGF-1 DES(1-3): the cited literature
Every study referenced in the IGF-1 DES(1-3) monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, IGF-1 DES(1-3) is studied at 50 mcg – 100 mcg per administration, typically once daily on training days. The reference walkthrough below maps each citation to what it actually showed.
References covered
DES(1-3)IGF-I: biological activity and IGFBP interaction
J. Endocrinol., 1991
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for IGF-1 DES(1-3).